Phase 1/2 pooled analysis of garsorasib in KRAS G12C-mutated advanced pancreatic cancer, reporting encouraging antitumor activity and tolerability.
Cannabis/CBD Oil
Cannabis/CBD Oil is a supplement, botanical, or biologic intervention discussed for symptom support, inflammation, immune modulation, metabolism, detoxification, or direct anticancer claims depending on the source. In cancer care, it should be evaluated by evidence level, intended use, safety, interactions, and whether it is being used as conventional treatment, supportive care, an experimental adjunct, or an alternative claim.
Patient-facing explanation of the Gerson therapy diet/protocol, including foods, claimed rationale, and safety/evidence concerns. Useful for public-facing context on natural-only cancer protocols.
Protocol for a systematic review and meta-analysis on the microbiome in pancreatic cancer and its precursor states.
MD Anderson patient education article on symptom-oriented acupuncture during cancer treatment, symptoms addressed, and safety screening.
NCI overview explaining that cancer patients may use CAM to cope with treatment side effects, comfort themselves, or try to treat cancer, and that CAM should be discussed with the care team. Used to frame grounding as supportive rather than curative.
Consumer health overview explaining what RSO is, high-THC content, legal status, and evidence context around cancer claims.
Healthline article summarizing RSO claims, cannabis/cannabinoid research context, side effects, legal risks, and treatment cautions.
Overview of RSO, claimed cancer uses, THC content, side effects, and the state of research on cannabis and cancer.
Randomized controlled trial of a spiritual intervention for hope and spiritual well-being in people with cancer.
MD Anderson randomized pilot trial: neurofeedback group improved CIPN symptoms versus waitlist control, with EEG changes predictive of symptom reduction.
NCI PDQ review of the Gerson regimen, a natural-only/diet-detox cancer protocol. Included because it describes the protocol and evidence concerns; it does not establish effectiveness.
MSKCC herb monograph on cannabis, mechanisms, evidence, cautions, and oncology guidance.
NCI patient summary on cannabis/cannabinoids for symptoms and FDA approval status.
Official Phoenix Tears page describing Simpson's suggested RSO dosing schedule and related usage notes.
Official FAQ covering Rick Simpson's views on RSO production materials, cannabis strains, solvents, safety cautions, and preparation context.
Cancer Research UK: lab studies exist but no reliable human evidence; nerve/liver/kidney and drug-interaction concerns.
Official Phoenix Tears instructions page describing the Rick Simpson process for producing concentrated cannabis oil.
Official Phoenix Tears article discussing Rick Simpson's position on solvent residue concerns in finished cannabis oil.
Patient-advocate/wellness article connecting rebounding with lymphatic movement and describing Wark's personal cancer-recovery exercise routine.